PHARMA & LIFE SCIENCES: LATEST INTERVIEWS MORE INTERVIEWS
"With continued investments in AI and automation, we are accelerating the industry's shift to digital validation and data-driven decision-making."
"The demand for seamless phase transitions is growing, with integrated CRDMOs enabling better knowledge transfer and faster development."
"Digital transformation helps accelerate drug pipelines by reducing workload and increasing efficiency."
"From an innovation point of view, breaking the US$40/gram cost barrier for production of mAbs is a key objective this year."
PHARMA & LIFE SCIENCES: LATEST ARTICLES
Genome Editing Technologies: Beyond Science Fiction
December 03, 2024
Conciliating science and ethics
US Life Sciences: Oncology and CNS Lead the Way
October 31, 2024
Unprecedented strides in drug discovery and development mean growing hope for patients
PHARMA & LIFE SCIENCES: RECENTLY RELEASED PUBLICATIONS
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
